Log in

Relevant bibliographies by topics / Thrombose de stent / Journal articles

To see the other types of publications on this topic, follow the link: Thrombose de stent.

Journal articles on the topic 'Thrombose de stent'

Author: Grafiati

Published: 4 June 2021

Last updated: 9 November 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Thrombose de stent.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Gellen, B., and E. Teiger. "Thrombose de stent." Archives des Maladies du Coeur et des Vaisseaux - Pratique 2011, no. 196 (2011): 31–34. http://dx.doi.org/10.1016/s1261-694x(11)70202-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kallel, R., R. Hakim, and G. Rangé. "Thrombose de stent : quoi de neuf en 2017 ?" Annales de Cardiologie et d'Angéiologie 66, no. 6 (2017): 393–99. http://dx.doi.org/10.1016/j.ancard.2017.10.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Huhle, G., S. Lessmann, U. Hoffmann, et al. "Langzeitantikoagulation bei Patienten mit Leberzirrhose und Implantation eines transjugulären, intrahepatischen portosystemischen Shunts." Hämostaseologie 20, no. 02 (2000): 107–9. http://dx.doi.org/10.1055/s-0037-1619475.

Full text

Abstract:

ZusammenfassungDie Patienten mit Leberzirrhose und den Komplikationen einer portalen Hypertension erhalten zunehmend einen transjugulären, intrahepatischen portosystemischen Stent Shunt (TIPSS). Studien haben den Wert dieser Behandlung zur Rezidivprophylaxe von Ösophagusvarizenblutungen und einem therapieresistenten Aszites belegt. Die Limitierung einer Implantation eines TIPSS besteht jedoch in der Ausbildung von Stent-Thrombosen oder -Stenosen. Azetylsalizylsäure ist nicht erfolgreich in der Prophylaxe der Stent-Thrombose. Phenprocoumon führt hingegen zu einer signifikanten Offenheitsrate. O

APA, Harvard, Vancouver, ISO, and other styles

4

Lemesle, G., and C. Delhaye. "La thrombose de stent, de plus en plus rare !" Annales de Cardiologie et d'Angéiologie 60, no. 6 (2011): 338–46. http://dx.doi.org/10.1016/j.ancard.2011.09.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Grivel, Thierry. "Quels sont les facteurs de risque de thrombose de stent ?" Option/Bio 19, no. 399 (2008): 6. http://dx.doi.org/10.1016/s0992-5945(08)70112-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kaptein, Yvonne E. "Acute ST-elevation myocardial infarction due to in-stent thrombosis after administering tranexamic acid in a high cardiac risk patient." BMJ Case Reports 12, no. 4 (2019): e227957. http://dx.doi.org/10.1136/bcr-2018-227957.

Full text

Abstract:

Tranexamic acid (TXA) is an antifibrinolytic which minimises bleeding and transfusions, with thrombotic risk. Our patient had known coronary artery disease with post-TXA acute ST-elevation myocardial infarction (STEMI) due to in-stent thrombosis. He had five drug-eluting stents (DES): two overlapping DES in mid-LAD (3 years ago), and two overlapping DES in distal right coronary artery and one DES in obtuse-marginal (1.5 years ago). After TXA, both overlapping stent locations thrombosed. Of nine reports of post-TXA acute MI, only one had complex stent anatomy (bifurcation stent to left circumfl

APA, Harvard, Vancouver, ISO, and other styles

7

Leithäuser and Park. "Endovascular treatment of an occluded popliteal aneurysm with locoregional thrombolysis followed by stent graft exclusion." Vasa 38, no. 1 (2009): 85–90. http://dx.doi.org/10.1024/0301-1526.38.1.85.

Full text

Abstract:

Popliteal artery aneurysms can thrombose or cause distal embolization and are therefore potentially limb-threatening lesions. This report describes the case of a 70-year-old man with severe claudication due to a thrombosed aneurysm of the left popliteal artery. He gave consent for a locoregional thrombolytical therapy, but refused standard surgical treatment. Thus, we developed the idea to restore blood flow by means of thrombolysis first, and then to perform a definitive repair of the aneurysm after a period of time. After successful thrombolysis and after 14 days as an outpatient with weight

APA, Harvard, Vancouver, ISO, and other styles

8

Rangé, G., R. Hakim, C. Saint Etienne, et al. "Thrombose de stent : une bataille gagnée ? (Données du registre France PCI)." Annales de Cardiologie et d'Angéiologie 70, no. 6 (2021): 388–94. http://dx.doi.org/10.1016/j.ancard.2021.10.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Torre, Joanne, Mazen Hashisho, Cheng Lo, and Eugene Mohan. "Thrombose aiguë d’un stent de l’artère rénale et rein unique fonctionnel." Annales de Chirurgie Vasculaire 24, no. 7 (2010): 1037.e7–1037.e13. http://dx.doi.org/10.1016/j.acvfr.2011.02.027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Nelson, Peter R., and W. Anthony Lee. "Endovascular Treatment Of Popliteal Artery Aneurysms." Vascular 14, no. 5 (2006): 297–304. http://dx.doi.org/10.2310/6670.2006.00049.

Full text

Abstract:

Popliteal artery aneurysms are relatively uncommon but potentially limb-threatening lesions that can thrombose or cause distal embolization. Identification of these aneurysms, especially in patients with abdominal aortic aneurysms, is imperative, and prophylactic treatment with either surgical exclusion and bypass or endoluminal stent grafting is critical to prevent these poor outcomes. Endovascular approaches currently using the Viabahn stent graft offer several advantages, including a minimally invasive approach, fewer perioperative complications, and a faster recovery. This must be balanced

APA, Harvard, Vancouver, ISO, and other styles

11

Krapivsky, A., T. Altilar, C. Vockelmann, and F. Niroomand. "Hämolytische Anämie bei stummer gedeckter Perforation der linksventrikulären Vorderwand nach Stent-Thrombose." Herz 38, no. 6 (2012): 636–38. http://dx.doi.org/10.1007/s00059-012-3717-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Morishima, Yoshiyuki, Yuko Honda, and Chikako Kamisato. "Prevention of Stent Thrombosis in Rats by a Direct Oral Factor Xa Inhibitor Edoxaban." Pharmacology 103, no. 1-2 (2018): 17–22. http://dx.doi.org/10.1159/000494059.

Full text

Abstract:

Background/Aims: Stent thrombosis is a serious complication after percutaneous coronary intervention and femoropopliteal endovascular intervention. The aim of this study was to determine the antithrombotic effects of a direct factor Xa inhibitor edoxaban alone or in combination with antiplatelet agents in a rat model of stent thrombosis. Methods: Stainless steel stents (4 stents per rat) were placed in an extracorporeal arteriovenous shunt. The shunt was inserted into the carotid artery and the jugular vein in each rat to circulate blood. Stent thrombosis was induced by exposing the stents to

APA, Harvard, Vancouver, ISO, and other styles

13

Delpierre, S., C. Vantelon, S. Samandel, S. Lacaille, and S. Legrain. "Thrombose aiguë intra-stent coronaire après arrêt de l'acide acétylsalicylique en vue d'une coloscopie." La Revue de Médecine Interne 26, no. 8 (2005): 675–77. http://dx.doi.org/10.1016/j.revmed.2005.04.026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Kedev, S., G. Guagliumi, O. Valsechi, and M. Tespili. "Heparin-Coated versus Uncoated Palmaz-Schatz Stent in Native Coronary Circulation. A Randomized Study with Blind Angioscopic Assessment." International Journal of Artificial Organs 25, no. 5 (2002): 461–69. http://dx.doi.org/10.1177/039139880202500517.

Full text

Abstract:

The increasing use of stenting to treat more complex lesions and highly thrombogenic situations still carries higher risk for subacute stent thrombosis. To assess new heparin-coated stents in a more stringent reality, 40 consecutive patients were randomized in 1:1 ratio to receive either heparin-coated (group 1, 25 stents) or uncoated Palmaz-Schatz stents (group 2, 32 stents). The two groups were similar in baseline clinical, pre-and post-procedural angiographic and angioscopic characteristics. High pressure stent deployment without intravascular ultrasound guidance was used. All pts received

APA, Harvard, Vancouver, ISO, and other styles

15

Jarrot, P. A., C. Brasselet, S. Duval, et al. "Thrombose aiguë de stent coronaire révélant un syndrome des antiphospholipides : à propos de deux observations." La Revue de Médecine Interne 33 (December 2012): A92. http://dx.doi.org/10.1016/j.revmed.2012.10.133.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Mboup, M. C., B. Moquet, A. Zabalawi, and R. Delaunay. "Thrombose très tardive d’un stent nu dix ans après son implantation : à propos d’une observation." Annales de Cardiologie et d'Angéiologie 62, no. 6 (2013): 435–37. http://dx.doi.org/10.1016/j.ancard.2012.04.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Afzal, Ashwad, Bimal Patel, Neel Patel, Sudhakar Sattur, and Vinod Patel. "Simultaneous Two-Vessel Subacute Stent Thrombosis Caused by Clopidogrel Resistance from CYP2C19 Polymorphism." Case Reports in Medicine 2016 (2016): 1–4. http://dx.doi.org/10.1155/2016/2312078.

Full text

Abstract:

Clopidogrel resistance from CYP2C19 polymorphism has been associated with stent thrombosis in patients undergoing percutaneous coronary intervention with drug-eluting stents. We present a case of a 76-year-old male who received drug-eluting stents to the right coronary artery and left anterior descending artery for non-ST elevation myocardial infarction and was discharged on dual antiplatelet therapy with aspirin and clopidogrel. He subsequently presented with chest pain from anterior, anteroseptal, and inferior ST segment elevation myocardial infarction. An emergent coronary angiogram reveale

APA, Harvard, Vancouver, ISO, and other styles

18

Gao, Junqing Q., Jianpu P. Zheng, Huigen G. Jin, et al. "A new rapamycin-abluminally coated chitosan/heparin stent system accelerates early re-endothelialisation and improves anti-coagulant properties in porcine coronary artery models." Clinical & Investigative Medicine 37, no. 6 (2014): 395. http://dx.doi.org/10.25011/cim.v37i6.22244.

Full text

Abstract:

Purpose: Drug-eluting stents (DES) in percutaneous coronary intervention are more effective in preventing in-stent restenosis compared with bare metal stents (BMS); however, DES may cause late stent thrombosis, which has limited its use. In this study, the functional properties of a newly developed DES (RAP/CS/HEP), in which rapamycin was abluminally-loaded onto a chitosan/heparin coating stent (CS/HEP), were investigated in large animal artery injury models. Methods: The effectiveness of BMS, RAP (the traditional version of rapamycin DES), CS/HEP and RAP/CS/HEP stents in preventing coagulatio

APA, Harvard, Vancouver, ISO, and other styles

19

Lawson, Matthew F., Gregory L. Fautheree, Michael F. Waters, David A. Decker, J. D. Mocco, and Brian L. Hoh. "Acute Intraprocedural Thrombus Formation During Wingspan Intracranial Stent Placement for Intracranial Atherosclerotic Disease." Operative Neurosurgery 67, no. 3 (2010): ons166—ons170. http://dx.doi.org/10.1227/01.neu.0000380948.85926.3c.

Full text

Abstract:

Abstract BACKGROUND: Treatment of intracranial atherosclerotic disease with the Wingspan-Gateway intracranial stent and balloon angioplasty system has been reported in several multicenter registries. To date, the incidence of acute intraprocedural thrombus formation during Wingspan stent placement has not been reported. OBJECTIVE: We reviewed the incidence of acute thrombus formation, treatment, and outcome for patients who underwent Wingspan stent placement by the senior author (B.L.H.) between June 2006 and April 2009. METHODS: We routinely perform angiograms every 10 minutes for at least 30

APA, Harvard, Vancouver, ISO, and other styles

20

Zahoor Soomro, Zuhaib, Asad Aslam Korejo, Khalid Iqbal Bhatti, Jawaid Akbar Sial, and Gul Hassan Brohi. "Frequency of Acute Stent Thrombosis after Primary Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction." Pakistan Journal of Medical and Health Sciences 15, no. 9 (2021): 2550–53. http://dx.doi.org/10.53350/pjmhs211592550.

Full text

Abstract:

Objective: To determine the frequency of acute stent thrombosis after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. Study Design: Descriptive cross sectional study. Place and Duration of Study: Department of Cardiology, National Institute of Cardiovascular Disease Hospital, Karachi from 30th 2017 to 31st December 2017. Methodology: One hundred and sixty three patients will undergo primary percutaneous coronary intervention and stent either drug-eluting stents (coated with medication) or bare-metal stent was placed. Patients who developed sudden

APA, Harvard, Vancouver, ISO, and other styles

21

Filali, Thouraya, Dhaker Lahidheb, Wafa Fehri, Mehdi Gommidh, Nadhem Hajlaoui, and Habib Haouala. "Réouverture d’un pontage artériel mammaire dans les suites d’une thrombose de stent sur le réseau natif." La Presse Médicale 41, no. 11 (2012): 1160–62. http://dx.doi.org/10.1016/j.lpm.2011.11.022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Cheaito, R., A. Tritar, A. Scemama, et al. "Thrombose coronaire très tardive par fracture du stent actif. Cas clinique et revue de la littérature." Annales de Cardiologie et d'Angéiologie 64, no. 6 (2015): 487–91. http://dx.doi.org/10.1016/j.ancard.2015.09.060.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Lindh, Mats, Martin Malina, Krasnodar Ivancev, Jan Brunkwall, and Bengt Lindblad. "Endovascular Stent-Anchored Aortic Grafts: A Comparison between Self-Expanding and Balloon-Expandable Stents in Minipigs." Journal of Endovascular Therapy 3, no. 3 (1996): 284–89. http://dx.doi.org/10.1177/152660289600300307.

Full text

Abstract:

Purpose: To study endovascular graft attachment with self-expanding Gianturco Z-stents and balloon-expanded Palmaz stents and the effect of these devices on the renal ostia. Methods: Ten stent-grafts were constructed, 5 with Gianturco Z-stents and 5 with Palmaz stents. The endografts were implanted under fluoroscopic guidance into the abdominal aorta of 10 pigs so that the uncovered portion of the proximal stent extended over the renal artery orifices. Distal aortic blood pressure and flow were measured before and after graft placement and 1 hour postprocedure. The aorta was then exposed surgi

APA, Harvard, Vancouver, ISO, and other styles

24

Boufi, Mourad, Bastien Orsini, Dona Bianca, Olivier Hartung, Philippe Brunet, and Yves S. Alimi. "Thrombose de l’artère rénale par fracture de stent: Le risque d’un piège de l’artère rénale non diagnostiqué." Annales de Chirurgie Vasculaire 24, no. 7 (2010): 1038.e1–1038.e4. http://dx.doi.org/10.1016/j.acvfr.2011.02.028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Liu, J. M., W. Y. Zhao, X. Zhang, Y. Xu, B. Hong, and Q. H. Huang. "Pathology of Stented Common Carotid Aneurysm in Dogs." Interventional Neuroradiology 11, no. 4 (2005): 333–40. http://dx.doi.org/10.1177/159101990501100405.

Full text

Abstract:

To elucidate focal successive histological responses of the neck of wide-necked aneurysm after single stent implantation and stent-assisted coiling, an experimental wide-necked aneurysm model was surgically created in bilateral common carotid arteries of adult dogs. Balloon-expandable porous stents were positioned across the aneurysm necks on both sides. The aneurysm cavity of one side was additionally loosely coiled with Gugliemi detachable coils after stent implantation. The dogs were followed up with ultrasonography and angiography, then sacrificed at two days, one month, and one year and t

APA, Harvard, Vancouver, ISO, and other styles

26

Alazzoni, Ashraf, Ayman Al-Saleh, and Sanjit S. Jolly. "Everolimus-Eluting versus Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention: Meta-Analysis of Randomized Trials." Thrombosis 2012 (May 9, 2012): 1–8. http://dx.doi.org/10.1155/2012/126369.

Full text

Abstract:

Background. Individual randomized trials have suggested that everolimus-eluting stents may have improved clinical outcomes compared to paclitaxel-eluting stents, but individual trials are underpowered to examine outcomes such as mortality and very late stent thrombosis. Methods. Medline, Cochrane, and conference proceedings were searched for randomized trials comparing everolimus versus paclitaxel-eluting stents for percutaneous coronary intervention. Results. 6792 patients were included from 4 randomized controlled trials. Stent thrombosis was reduced with everolimus stents versus paclitaxel

APA, Harvard, Vancouver, ISO, and other styles

27

Sibbing, Dirk, Karl-Ludwig Laugwitz, Lorenz Bott-Flügel, and Jürgen Pache. "Very Late Stent Thrombosis 42 Months after Implantation of Sirolimus-Eluting Stent and Discontinuation of Antiplatelet Therapy." Case Reports in Medicine 2009 (2009): 1–2. http://dx.doi.org/10.1155/2009/713292.

Full text

Abstract:

Although safety profiles of sirolimus-eluting stents do not seem to differ in short-to-medium term from those of bare-metal stents, late stent thrombosis after deployment of drug-eluting stents has emerged as a potential safety concern in the era of high-pressure stent implantation. Here, we describe the case of a patient with acute myocardial infarction due to stent thrombosis of a sirolimus-eluting stent 42 months after stent deployment and 5 weeks after discontinuation of aspirin treatment. To the best of our knowledge, this is one of the most delayed cases of sirolimus-eluting stent thromb

APA, Harvard, Vancouver, ISO, and other styles

28

Djuric, Predrag, Slobodan Obradovic, Zoran Stajic, et al. "Very late stent thrombosis of bare-metal coronary stent nine years after primary percutaneous coronary intervention." Vojnosanitetski pregled 73, no. 8 (2016): 774–78. http://dx.doi.org/10.2298/vsp141222053d.

Full text

Abstract:

Introduction. Stent thrombosis (ST) in clinical practice can be classified according to time of onset as early (0?30 days after stent implantation), which is further divided into acute (< 24 hours) and subacute (1?30 days), late (> 30 days) and very late (> 12 months). Myocardial reinfaction due to very late ST in a patient receiving antithrombotic therapy is very rare, and potentially fatal. The procedure alone and related mechanical factors seem to be associated with acute/subacute ST. On the other hand, in-stent neoathero-sclerosis, inflammation, premature cessation of antiplatelet

APA, Harvard, Vancouver, ISO, and other styles

29

Petrovic, Milovan, Miroslav Bikicki, Gordana Panic, Tibor Canji, Ilija Srdanovic, and Vladimir Ivanovic. "Late stent thrombosis." Medical review 62, no. 1-2 (2009): 79–82. http://dx.doi.org/10.2298/mpns0902079p.

Full text

Abstract:

Introduction. Late stent thrombosis is a serious complication after stent Implantation and it can lead to the development of acute myocardial infarction or death. A case report. A 43-year-old patient was admitted to our clinic to coronary care unit. He was diagnosed with acute ST elevation myocardial reinfarction of inferoposterior localisation and with right ventricular myocardial infarction. Eighteen months ago, he had acute myocardial infarction of the same localisation, and at the same time, PCI (Percutaneous Coronary Intervention) was performed in acute phase, and two bare metal stents we

APA, Harvard, Vancouver, ISO, and other styles

30

Feng, HQ, SB Wang, YG Wang, et al. "Finite element analysis and animal test verification of nitinol alloy iliac vein stent performance." Proceedings of the Institution of Mechanical Engineers, Part C: Journal of Mechanical Engineering Science 233, no. 17 (2019): 6197–208. http://dx.doi.org/10.1177/0954406219861127.

Full text

Abstract:

The design and fatigue strength of a nitinol iliac vein stent (NIVS) proposed in this study are assessed using the finite element analysis method. The influence of stent diameter and different release scales on its strength, lifespan and biomechanical properties of the vein wall is analyzed for self-developed NIVS of three different diameters (12, 14 and 16mm) and length of 26mm, which were implanted into the corresponding iliac vein with different release scales (80% and 90%). The results obtained strongly indicate that with an increase in the release scale, the equivalent elastic strain, saf

APA, Harvard, Vancouver, ISO, and other styles

31

Ooi, Yinn K., R. Allen Ligon, Michael Kelleman, et al. "Thromboprophylaxis strategies for children with single-ventricle circulations (superior or total cavo-pulmonary connections) after stent implantation." Cardiology in the Young 29, no. 7 (2019): 877–84. http://dx.doi.org/10.1017/s1047951119000969.

Full text

Abstract:

AbstractObjective:To define optimal thromboprophylaxis strategy after stent implantation in superior or total cavopulmonary connections.Background:Stent thrombosis is a rare complication of intravascular stenting, with a perceived higher risk in single-ventricle patients.Methods:All patients who underwent stent implantation within superior or total cavopulmonary connections (caval vein, innominate vein, Fontan, or branch pulmonary arteries) were included. Cohort was divided into aspirin therapy alone versus advanced anticoagulation, including warfarin, enoxaparin, heparin, or clopidogrel. Prim

APA, Harvard, Vancouver, ISO, and other styles

32

Formigli, D., A. Parente, E. Pirozzi, et al. "P42 ACUTE STENT THROMBOSIS IN CATH LAB DURING OPTIMIZED PCI: HOW TO RECOGNIZE IT AND POSSIBLE TREATMENT." European Heart Journal Supplements 25, Supplement_D (2023): D56. http://dx.doi.org/10.1093/eurheartjsupp/suad111.128.

Full text

Abstract:

Abstract Angiographic Acute Stent Thrombosis occur in 0.5%–2% of procedures.OCT–PCI or Optimized PCI represents a new approach particularly indicated in complex high thrombotic risk lesions, in patients at high bleeding risk with need for short DAPT and in the treatment of vulnerable plaques. Post–stent OCT thrombus finding was defined in previous studies as mass with diameter ≥250μm attached to the stent struts, was present until 40% of cases and is associated with definite angiographic thrombosis. Outcome of OCT thrombus is generally favorable although in about 25% there may be a progression

APA, Harvard, Vancouver, ISO, and other styles

33

Shi, Xiaoli, Jin Wang, Gui Zhang, et al. "Safety study of malapposition of the bio-corrodible nitrided iron stent in vivo." Nanotechnology Reviews 10, no. 1 (2021): 839–46. http://dx.doi.org/10.1515/ntrev-2021-0062.

Full text

Abstract:

Abstract To evaluate the safety of stent malapposition of corrodible nitride iron stent as biodegradable cardiovascular implants, a total of 108 stents were implanted into the abdominal aortas, iliac arteries, and iliac artery bifurcations of 36 New Zealand white rabbits separately. Each rabbit was implanted with three stents. After a follow-up period of 3 months, no thrombus and embolism were found in local and downstream vessels. And no other adverse events occurred either. Stent strut covered by endothelial layer started to show signs of degradation, while struts exposed to bifurcated blood

APA, Harvard, Vancouver, ISO, and other styles

34

Gherasie, Flavius-Alexandru, Chioncel Valentin, and Stefan-Sebastian Busnatu. "Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?" Journal of Personalized Medicine 13, no. 5 (2023): 753. http://dx.doi.org/10.3390/jpm13050753.

Full text

Abstract:

In patients undergoing percutaneous coronary intervention, the second-generation drug-eluting stents (DES) are considered the gold standard of care for revascularization. By reducing neointimal hyperplasia, drug-eluting coronary stents decrease the need for repeat revascularizations compared with conventional coronary stents without an antiproliferative drug coating. It is important to note that early-generation DESs were associated with an increased risk of very late stent thrombosis, most likely due to delayed endothelialization or a delayed hypersensitivity reaction to the polymer. Studies

APA, Harvard, Vancouver, ISO, and other styles

35

Karsonovich, Torin, and Ajeet Gordhan. "Endovascular management of symptomatic cerebral aneurysm thromboembolism due to pre-aneurysmal arterial stenosis." SAGE Open Medical Case Reports 5 (January 1, 2017): 2050313X1773026. http://dx.doi.org/10.1177/2050313x17730263.

Full text

Abstract:

Background: Pre-aneurysmal internal carotid steno-occlusive disease resulting in cerebral intra-aneurysmal thrombosis and subsequent embolic infarction has not been previously described. Conclusion: Antithrombotic treatment for dissolution of the thrombus and pre-aneurysmal stent angioplasty followed by Pipeline embolization flow diverter placement through the aneurysm is a safe and feasible management option.

APA, Harvard, Vancouver, ISO, and other styles

36

Srdanovic, Iva. "Late Catch-up In-Stent Restenosis and Stent Thrombosis for 2nd Generation Biodegradable Polymer Drug Eluting Stents." Pharmaceutics and Pharmacology Research 5, no. 3 (2022): 01–07. http://dx.doi.org/10.31579/2693-7247/061.

Full text

Abstract:

Second generation drug-eluting stents (DES) have reduced the rate of in-stent restenosis (ISR) to < 10% [1, 2] in patients undergoing PCI. However, late catch-up in-stent restenosis remains an issue despite the advent in drug-eluting stent technology from 1st to 2nd generation drug eluting stents. The late catch-up phenomenon has been associated with serious consequences and adverse events and remains an important issue in modern practice, despite medical advances with more biocompatible and biodegradable polymers, as well as new therapeutic agents and thinner scaffolds in the development o

APA, Harvard, Vancouver, ISO, and other styles

37

Naser, Mohamad Younas. "REOCURRENCE OF STENT THROMBOSIS POST ANGIOPLASTY- A COMPHRENSIVE REVIEW." Journal of Applied Pharmaceutical Sciences and Research 7, no. 1 (2024): 13–21. http://dx.doi.org/10.31069/japsr.v7i1.03.

Full text

Abstract:

Coronary diseases are caused due to inability of arteries to carry sufficient oxygenated blood to the heart muscles. Mostly obstruction to the blood flow occurs due to formation of a clot in the blood vessels. Thrombosis leads to narrowing of blood vessels and to correct narrowed blood vessels a specialized medical device- stents are placed inside the vessels via angioplasty. Even after successful placement of stents and correction of blood vessel narrowing problem occurs. Stent thrombosis is such a common problem which occurs after percutaneous coronary intervention. It occurs due to formatio

APA, Harvard, Vancouver, ISO, and other styles

38

Gopalakrishnan, Mukesh, and Amir Lotfi. "Stent Thrombosis." Seminars in Thrombosis and Hemostasis 44, no. 01 (2017): 046–51. http://dx.doi.org/10.1055/s-0037-1606178.

Full text

Abstract:

AbstractThe most dreaded complication with percutaneous coronary intervention with stents, either bare-metal or drug-eluting stents is stent thrombosis (ST) and it has a significant detrimental effect on the outcome for the patient. The initial attempts at intervention with bare-metal stents had much higher rates of ST compared with what is currently prevailing in the modern interventional world. Significant changes with respect to the stent technology, pharmacology, and most importantly our understanding of this phenomenon have decreased the risk of ST. There are many factors that can be perf

APA, Harvard, Vancouver, ISO, and other styles

39

Ansari, Sameer A., Jeffrey P. Lassig, Ewen Nicol, B. Gregory Thompson, Joseph J. Gemmete, and Dheeraj Gandhi. "Thrombosis of a Fusiform Intracranial Aneurysm Induced by Overlapping Neuroform Stents Case Report." Neurosurgery 60, no. 5 (2007): E950—E951. http://dx.doi.org/10.1227/01.neu.0000255427.08926.dc.

Full text

Abstract:

Abstract OBJECTIVE To present a case of a true fusiform basilar artery aneurysm that underwent spontaneous thrombosis after placement of two overlapping Neuroform stents (Boston Scientific/Target, Fremont, CA). CLINICAL PRESENTATION A 45-year-old woman with transient syncopal episodes experienced a fall and presented to the emergency room. Incidentally, a non-contrast head computed tomographic scan and digital subtraction angiography demonstrated an unruptured, fusiform mid-basilar artery aneurysm. INTERVENTION Endovascular treatment was initiated by using a stent-assisted coil embolization te

APA, Harvard, Vancouver, ISO, and other styles

40

Lehot, J. J., V. Piriou, G. Durand de Gevigney, and P. Coriat. "Le patient à risque de thrombose de stent coronaire en période périopératoire : une situation de plus en plus fréquente." Annales Françaises d'Anesthésie et de Réanimation 24, no. 10 (2005): 1247–49. http://dx.doi.org/10.1016/j.annfar.2005.07.068.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Mshelbwala, Fakilahyel S., Mir B. Basir, Brittany Fuller, and Khaldoon Alaswad. "Peri-Contrast Staining as a Marker of Stent Failure: Restenosis, Thrombosis, and Fracture." Case Reports in Cardiology 2021 (September 3, 2021): 1–4. http://dx.doi.org/10.1155/2021/4688228.

Full text

Abstract:

The introduction of stents has led to significant improvement in the management of coronary artery disease. In-stent thrombosis, target lesion revascularization, and stent fracture (SF) have been identified as causes of in-stent restenosis. Peri-contrast staining (PSS) has been associated with in-stent restenosis, stent thrombosis, stent fracture, and the development of coronary aneurysm. As the frequency of patients with first generation sirolimus-eluting coronary stents becomes infrequent; PSS may go unrecognized. Herein, we present a patient with a decade of longitudinal follow-up, who deve

APA, Harvard, Vancouver, ISO, and other styles

42

Marino, Angelo G., and Alfred Lee. "Maintained patency and symptom resolution after treatment of recurrent in-stent thrombosis with novel RevCore thrombectomy system: A case report." American Journal of Interventional Radiology 8 (June 29, 2024): 6. http://dx.doi.org/10.25259/ajir_8_2024.

Full text

Abstract:

In-stent thrombosis (IST) is a frequent complication following intervention to remove thrombus and treat residual venous outflow obstruction or stenosis. Treatment is often limited to venoplasty and stent relining, which only temporarily restores stent patency until rethrombosis inevitably occurs. As a result, disease management becomes a cycle of repeated recanalization procedures without long-term relief. This report highlights an early use case of a novel device capable of debulking material in the peripheral vasculature and restoring patency to occluded stents. A 60-year-old male with a 25

APA, Harvard, Vancouver, ISO, and other styles

43

Heublein, Bernd, Cem Özbek, and Klaus Pethig. "Silicon Carbide-Coated Stents: Clinical Experience in Coronary Lesions with Increased Thrombotic Risk." Journal of Endovascular Therapy 5, no. 1 (1998): 32–36. http://dx.doi.org/10.1177/152660289800500107.

Full text

Abstract:

Purpose: To report the results of a prospective, nonrandomized, multicenter study of a semiconductor-coated stent in coronary lesions at high risk for stent thrombosis. Methods: A balloon-expandable tantalum stent was coated with silicon carbide to enhance thromboresistance (Tensum). Patients were enrolled in an observational study that compared coronary stenting with the Tensum stent in patients at low risk for stent thrombosis against those with factors predisposing to local thrombosis (acute myocardial infarction, small vessel diameter, recanalized chronic total occlusion, saphenous vein by

APA, Harvard, Vancouver, ISO, and other styles

44

Tinanda Tarigan, Daniel Sukmadja, Kaka Citta Prasiddha, and Rizkan Triatmaja. "Comparative efficacy of drug-eluting balloon and drug-eluting stent for treatment of in-stent restenosis: a systematic review and meta-analysis." Journal of the Pakistan Medical Association 74, no. 6 (Supple) (2024): S51—S56. http://dx.doi.org/10.47391/jpma.s6-acsa-09.

Full text

Abstract:

Objective: To compare the efficacy of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. Method: The systematic review was conducted from January to February 2022, and comprised literature search on PubMed, ProQuest, Cochrane Library and Google Scholar databases with relevant key words to locate randomised controlled trials and observational studies published between 2000 and 2022 that compared drugeluting balloons and drug-eluting stents in the treatment of in-stent restenosis. The outcomes were all-cause death, cardiovascular death, major adverse cardiovascular ev

APA, Harvard, Vancouver, ISO, and other styles

45

Che, Haijie, Jingjun Jiang, Hao Liu, Jichang Wei, and Xiaoming Zhang. "Preliminary report of a new type of braided vein stent in animals." Phlebology: The Journal of Venous Disease 34, no. 4 (2018): 246–56. http://dx.doi.org/10.1177/0268355518801172.

Full text

Abstract:

Background Iliofemoral vein stenosis or occlusion is a common cause of severe chronic venous insufficiency. Endovascular venous stenting has become a preferred treatment because it is minimally invasive and has a high safety profile. Despite the wide application of the wallstent, it is not specifically designed for veins. There are currently few studies on braided stents in the field of veins. We designed a novel braided vein stent, which has higher radial resistive force and more optimized looped ends structure compared with the wallstent. The purpose of this study was to evaluate the safety

APA, Harvard, Vancouver, ISO, and other styles

46

Lagache, Manuel, Ricardo Coppel, Gérard Finet, et al. "Impact of Malapposed and Overlapping Stents on Hemodynamics: A 2D Parametric Computational Fluid Dynamics Study." Mathematics 9, no. 8 (2021): 795. http://dx.doi.org/10.3390/math9080795.

Full text

Abstract:

Despite significant progress, malapposed or overlapped stents are a complication that affects daily percutaneous coronary intervention (PCI) procedures. These malapposed stents affect blood flow and create a micro re-circulatory environment. These disturbances are often associated with a change in Wall Shear Stress (WSS), Time-averaged WSS (TAWSS), relative residence time (RRT) and oscillatory character of WSS and disrupt the delicate balance of vascular biology, providing a possible source of thrombosis and restenosis. In this study, 2D axisymmetric parametric computational fluid dynamics (CF

APA, Harvard, Vancouver, ISO, and other styles

47

Vučić, Miodrag, and Nebojša Vacić. "Percutaneous coronary interventions in patient with hemophilia A, partial gastrectomy and recurrent myocardial infarction." Medicinska rec 1, no. 2 (2020): 15–18. http://dx.doi.org/10.5937/medrec2001015v.

Full text

Abstract:

Acute coronary syndrome is not rare in patients with haemophilia. We report a case of 55-year-old male patient with haemophilia A and gastric resection with Billroth II anastomosis with repeated STEMI and NSTEMI who was successfully treated by PTCA with stent implantation. Patient was admitted to the emergency department (April 2010). Coronary angiography revealed occlusion of mid-RCA, suboclusion of proximal LAD and also of medial Diagonal (Dg) brunch. Bare metal stent was implanted into the RCA. Two-years after (March 2012) patient was readmitted due to chest pain. Coronary angiography showe

APA, Harvard, Vancouver, ISO, and other styles

48

Liou, Kevin, and Nigel Jepson. "Very Late Stent Thrombosis 11 Years after Implantation of a Drug-Eluting Stent." Texas Heart Institute Journal 42, no. 5 (2015): 487–90. http://dx.doi.org/10.14503/thij-14-4550.

Full text

Abstract:

Very late stent thrombosis is an infrequent yet potentially fatal complication associated with drug-eluting stents. We report the case of an 88-year-old man who sustained an ST-segment-elevation myocardial infarction 11 years after initial sirolimus-eluting stent implantation. Optical coherence tomograms of the lesion showed that the focal incomplete endothelialization of the stent struts was the likely cause; neointimal formation, neoatherosclerosis, and late stent malapposition might also have contributed. To our knowledge, this is the longest reported intervening period between stent insert

APA, Harvard, Vancouver, ISO, and other styles

49

Chen, Henry Y., Bon-Kwon Koo, and Ghassan S. Kassab. "Impact of bifurcation dual stenting on endothelial shear stress." Journal of Applied Physiology 119, no. 6 (2015): 627–32. http://dx.doi.org/10.1152/japplphysiol.00082.2015.

Full text

Abstract:

Despite advances in percutaneous coronary interventions and the introduction of drug eluding stents, in-stent restenosis and stent thrombosis remain a clinically significant problem for bifurcations. The aim of this study is to determine the effect of dual bifurcation stenting on hemodynamic parameters known to influence restenosis and thrombosis. We hypothesized that double stenting, especially with a longer side branch (SB) stent, likely has a negative effect on wall shear stress (WSS), WSS gradient (WSSG), and oscillatory shear index (OSI). To test this hypothesis, we developed computationa

APA, Harvard, Vancouver, ISO, and other styles

50

Shaikh, Sanaullah, Vashu Mal, Jagdesh Kumar, Suhail Ahmed, Faraz Farooq Memon, and Bilawal Adrani. "The Frequency of Early Subacute Stent Thrombosis after Primary Percutaneous Coronary Intervention in Patients with St-Segment Elevation Myocardial Infarction." Pakistan Journal of Medical and Health Sciences 16, no. 1 (2022): 530–34. http://dx.doi.org/10.53350/pjmhs22161530.

Full text

Abstract:

Introduction: Acute coronary syndrome(ACS) is associated with activation ofplateletsand thecoagulationsystem which could influence the incidence of early stentthrombosis(EST).Stent thrombosis is a relatively uncommon phenomenon, yet it is a serious complication which often presents as an ST-segment elevation myocardial infarction (STEMI) and/or sudden cardiac death1,2.Stent thrombosis (ST) is an uncommon but life-threatening complication after percutaneous coronary intervention (PCI), frequently manifesting as acute coronary syndrome (ACS) or even cardiac death.Platelet activation and the heig

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!